User:Mr. Ibrahem/Cabotegravir/rilpivirine

Cabotegravir/rilpivirine, sold under the brand name Cabenuva, is a co-packaged medication used to treat HIV/AIDS. In those who are at least 12 years old, it is generally all the medications needed to treat the disease. It is given by injection into a muscle. It is packaged with two separate vials.

Common side effects include injection site reactions, fever, tiredness, headache, musculoskeletal pain, nausea, sleep disorders, dizziness, and rash. Other side effects may include allergic reactions, liver problems, and depression. It contains cabotegravir, an HIV-1 integrase strand transfer inhibitor (INSTI), and rilpivirine, an HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI).

The combination was approved for medical use in Canada and Europe in 2020 and the United States in 2021. In Europe, the two medications are approved separately. In the United States it costs about 4,400 USD per month as of 2022.